Recovery of HIV encephalopathy in perinatally infected children on antiretroviral therapy
Year: 2020
Type: article
DOI: 10.1111/dmcn.14639
Language: English
Topic: HIV Research and Treatment
Subfield: Virology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
Funders: United States Agency for International Development, GlaxoSmithKline, National Research Foundation, South African Medical Research Council, Harry Crossley Foundation, National Institutes of Health, Centers for Disease Control and Prevention, National Institute of Allergy and Infectious Diseases, Eunice Kennedy Shriver National Institute of Child Health and Human Development
Awards: G342295615, G3525334731, G3826536175, G401530712, G4333539396, G4532656898, G5265196040, G5374869926, G5490786453, G5690887495, PHARMACOKINETICS AND TOXICITY OF 2ND LINE ANTI-TB DRUGS IN HIV-INFECTED CHILDREN, CIPRA-SA: Safeguard the household: comprehensive AIDS research: Extension, G700131457, Screening for atherosclerotic vascular disease in HIV-infected children, Longitudinal Neuroimaging and Cognitive Study of HIV-Infected Children, G8360964256, The Utility of Interferon-Gamma Release Assays in TB-HIV co-infected Children, San Diego Center for AIDS Research (SD CFAR)
OpenAlex ID: W3048390274
